Search dm+d | This VMP cannot be matched against our prescribing data.
| Name | Bortezomib 2.5mg powder for solution for injection vials |
| Virtual Therapeutic Moiety | Bortezomib |
| Basis of preferred name | rINN - Recommended International Non-proprietary |
| Prescribing status | Valid as a prescribable product |
| Sugar free | ✗ |
| Gluten free | ✗ |
| Preservative free | ✗ |
| CFC free | ✗ |
| Dose form | Discrete |
| Unit dose form size | 1.000 |
| Unit dose form units | vial |
| Unit dose unit of measure | vial |
| Virtual Product Ingredient | |
|---|---|
| Ingredient | Bortezomib |
| Basis of pharmaceutical strength | Based on Ingredient Substance |
| Strength value numerator | 2.500 |
| Strength value numerator unit | mg |
| Ontology Drug Form & Route | |
| Form & Route | solutioninjection.subcutaneous |
| Ontology Drug Form & Route | |
| Form & Route | solutioninjection.intravenous |
| Dose Form | |
| Formulation | Powder for solution for injection |
| Drug Route | |
| Route | Intravenous |
| Drug Route | |
| Route | Subcutaneous |
| Controlled Drug Prescribing Information | |
| Controlled Drug category | No Controlled Drug Status |
| Actual Medicinal Products | |
| Bortezomib 2.5mg powder for solution for injection vials (Aspire Pharma Ltd) | |
| Bortezomib 2.5mg powder for solution for injection vials (Pfizer Ltd) | |
| Virtual Medicinal Product Packs | |
| Bortezomib 2.5mg powder for solution for injection vials 1 vial | |
dm+d data retrieved from TRUD: release NHSBSA_6.0.0_20240603000001, imported on 3rd June 2024 at 04:58:20.